SCHEMBL11992201

SCHEMBL11992201

CC1(C)c2cc(-c3ccc(-c4ccc5ccc6cccnc6c5n4)cc3)ccc2-c2ccc(-c3ccc4c5c(cccc35)-c3c-4c(-c4ccccc4)c4ccccc4c3-c3ccccc3)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 6/20 0.33
AVPR2 P30518 1/20 0.33
AVPR1A P37288 1/20 0.33
PIM1 P11309 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
BRD4 O60885 1/20 0.31
BACE1 P56817 1/20 0.31
PARP1 P09874 1/20 0.31
CYP3A4 P08684 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
PDE4A P27815 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
GLO1 Q04760 2/20 0.30
CKS1B P61024 1/20 0.30
SKP2 Q13309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11992196 0.97 AVPR2 (0.34) TOP1AVPR2AVPR1APIM1PIM2
SCHEMBL11992182 0.90 TOP1 (0.36) TOP1PIM1PIM2BRD4PARP1
SCHEMBL11992184 0.88 CYP17A1 (0.36) TOP1PIM1PIM2BRD4CYP3A4
SCHEMBL11992190 0.88 BRD4 (0.39) TOP1PIM1PIM2BRD4PARP1
SCHEMBL11992193 0.88 TOP1 (0.39) TOP1PIM1PIM2PARP1CYP3A4
SCHEMBL11992185 0.88 TOP1 (0.39) TOP1PIM1PIM2PARP1CYP3A4
SCHEMBL11992195 0.87 BRD4 (0.37) TOP1PIM1PIM2BRD4PARP1
SCHEMBL11992310 0.87 TOP1 (0.37) TOP1PIM1PIM2BRD4PARP1
SCHEMBL11992177 0.87 TOP1 (0.37) TOP1PIM1PIM2BRD4CYP3A4
SCHEMBL11992172 0.87 TOP1 (0.36) TOP1PIM1PIM2BRD4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273002-B2 Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-01 US disclosed
US-9273002-B2 Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-01 US disclosed
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-08-23 US disclosed
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME KCNJ2, KCNE1, KCNK2 TOP1 2070/4885AVPR2 1814/4885AVPR1A 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.